Condition
Liver Transplant Failure and Rejection
Total Trials
5
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Unknown3
Active Not Recruiting1
Suspended1
Clinical Trials (5)
Showing 5 of 5 trials
NCT04756063Phase 4SuspendedPrimary
Parenteral Ascorbic Acid Repletion in TransplantatIon
NCT06153641Active Not Recruiting
Cytokeratin 18 Non-invasive Biomarker for Rejection in Liver Transplant Patients
NCT06103097UnknownPrimary
Histologic Evolution of Patients With Liver Transplantation
NCT04812054Not ApplicableUnknown
Dual Hypothermic Oxygenated Machine Perfusion in Liver Transplantation Using Allografts From Donors After Brain Death
NCT04694573Unknown
Multicenter CTS Pre-and Post-Transplantation Covid-19 Serum Studies
Showing all 5 trials